Printer Friendly

Browse Schizophrenia topic

Drug therapy subtopic



1-251 out of 251 article(s)
Title Author Type Date Words
United States : FDA Grants Priority Review for Three-Month Paliperidone Palmitate for the Treatment of Schizophrenia. Jan 20, 2015 426
FDA Grants Priority Review for Three-Month Paliperidone Palmitate for the Treatment of Schizophrenia. Jan 19, 2015 2435
CoMentis and Anvyl Announce the Initiation of Clinical Trials for APN1125 for the Treatment of Schizophrenia. Jan 9, 2015 549
CAMH discovery of novel drug target may lead to better treatment for schizophrenia. Dec 9, 2014 550
Janssen Submits New Drug Application to U.S. FDA for Three-Month Paliperidone Palmitate. Nov 19, 2014 2431
Shorts. Klotter, Jule Oct 1, 2014 3237
'Dimmer Switch' To Help Control Dopamine for Treatment of Schizophrenia. Disease/Disorder overview Aug 14, 2014 316
United States : Janssen Pharmaceuticals Seeks Expanded Label for Once-Monthly INVEGA SUSTENNA (paliperidone palmitate) to Show Delayed Time to Relapse Compared to Daily Oral Schizophrenia Therapies. Jul 16, 2014 396
Janssen Pharmaceuticals Seeks Expanded Label for Once-Monthly INVEGA SUSTENNA (paliperidone palmitate) to Show Delayed Time to Relapse Compared to Daily Oral Schizophrenia Therapies. Jul 14, 2014 2586
Undiagnosed metabolic syndrome and other adverse effects among clozapine users of Xhosa descent. Faasen, N.; Niehaus, D.J.H.; Koen, L.; Jordaan, E. Report Jul 1, 2014 3789
Japan : Dainippon Sumitomo Pharma and Takeda Announce the European Marketing Authorization for LatudaA(lurasidone) - a New Atypical Antipsychotic Medication for Adults with Schizophrenia. Apr 1, 2014 425
Dainippon Sumitomo Pharma and Takeda Announce the European Marketing Authorization for Latuda (lurasidone) - a New Atypical Antipsychotic Medication for Adults with Schizophrenia. Mar 28, 2014 2090
United States : Janssen Investigational Treatment for Schizophrenia Shows Positive Efficacy, Delays Relapse. Clinical report Mar 21, 2014 422
Janssen Investigational Treatment for Schizophrenia Shows Positive Efficacy, Delays Relapse. Clinical report Mar 20, 2014 2234
FDA Grants Fast Track Designation to Omeros' OMS824 Huntington's Disease Program. Feb 5, 2014 1016
New molecular breakthrough brings schizophrenia treatment closer to reality. Dec 31, 2013 247
Intra-Cellular Therapies Announces Positive Topline Phase II Clinical Results of ITI-007 for the Treatment of Schizophrenia. Dec 9, 2013 2894
Japan : Otsuka and Lundbeck's once-monthly Abilify MaintenaA (aripiprazole) now approved in Europe for maintenance treatment of schizophrenia in adult patients stabilized with oral aripiprazole. Nov 22, 2013 432
United States : Janssen Pharmaceuticals, Inc. to plead guilty and pay over $1.6 billion to resolve allegations of misbranding and filing false claims for its schizophrenia drug Risperdal. Nov 5, 2013 461
Five Scientific Posters Supporting the Efficacy and Tolerability of Once-Daily Lurasidone - A New Atypical Antipsychotic Treatment for Adults with Schizophrenia. Oct 14, 2013 1919
FDA Grants Orphan Drug Designation to Omeros' OMS824 for Huntington's Disease. Sep 30, 2013 988
Japan : Otsuka and Lundbeck receive positive CHMP opinion for Abilify Maintena(r) in schizophrenia. Sep 21, 2013 418
Psychotic Symptoms of Schizophrenia Caused by Faulty Brain Switch. Aug 21, 2013 444
AACC Annual Meeting Breaking Science Includes New Tests to Detect Life-Threatening Prostate Cancer, New Cystic Fibrosis Tests That Can Be Measured at the Point of Care, and New Ways to Determine the Safety of Drugs Used to Treat Schizophrenia and Bipolar Disorder. Jul 18, 2013 1053
University's challenge to improve treatment; Scientists' schizophrenia bid. Jul 2, 2013 408
New treatment for schizophrenia discovered. Jul 2, 2013 217
'Brain-shrinkage and schizophrenia' caused by drugs; WARNING TO TEENAGERS OVER DANGEROUS NEW SUBSTANCES. May 18, 2013 552
Omeros Requests Fast Track Designation for OMS824 for the Treatment of Huntington's Disease. May 1, 2013 824
Schizophrenia and Its Treatment Reviewed by NeuroPerspective. Mar 19, 2013 518
Reviva Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of RP5063 for the Treatment of Schizophrenia and Schizoaffective Disorder. Jan 14, 2013 837
BioLineRx to Announce Interim Results of Phase II/III Trial for Schizophrenia Drug During Week of March 18, 2013. Jan 7, 2013 1207
Alkermes Expands CNS Pipeline and Announces Positive Results from Phase 1 Study of ALKS 3831, a Novel Antipsychotic Therapy for the Treatment of Schizophrenia. Jan 3, 2013 1317
Vanda Receives Negative Opinion from CHMP on Fanaptum(TM) for the Treatment of Schizophrenia. Dec 13, 2012 883
Forest Laboratories Submits New Drug Application for Cariprazine for the Treatment of Both Schizophrenia and Manic or Mixed Episodes Associated with Bipolar I Disorder. Clinical report Nov 28, 2012 782
DSPE Regulatory Update: Acceptance of the European Medicines Agency Submission for an Atypical Antipsychotic Agent Lurasidone. Oct 25, 2012 670
DSP and Takeda Announce the Acceptance of the European Medicines Agency Submission of an Atypical Antipsychotic Agent Lurasidone. Oct 25, 2012 937
DSP and Takeda Announce the Acceptance of the European Medicines Agency Submission of an Atypical Antipsychotic Agent Lurasidone. Oct 25, 2012 950
Research and Markets: Key Findings from Treatment Algorithms: Schizophrenia. Oct 5, 2012 290
United States : FDA Approves Expansion of Dosing Window to Help Avoid Missed Doses in INVEGA SUSTENNA Updated Product Label. Sep 28, 2012 363
BioLineRx Announces Publication of EAGLE Study Results Demonstrating BL-1020's Efficacy in Improving Cognitive Function in Schizophrenia Patients. Clinical report Sep 27, 2012 1204
Psychology. Author abstract Sep 22, 2012 2658
Antipsychotic drug therapy: proceed with caution. Casey, Georgina Sep 1, 2012 4584
Lilly Stops Phase III Development of Pomaglumetad Methionil For the Treatment of Schizophrenia Based on Efficacy Results. Clinical report Aug 29, 2012 599
New drug target for schizophrenia identified. Aug 14, 2012 461
Antipsychotics need to pile up: new insights explain delayed action in schizophrenia drugs. Sanders, Laura Jul 14, 2012 445
Research and Markets: Pharmacological and Psychosocial Treatments in Schizophrenia. Jun 20, 2012 429
Depot antipsychotics boost compliance. Zoler, Mitchel L. Jun 1, 2012 980
A placebo-controlled trial of bupropion for improving the positive and negative symptoms of schizophrenia. Rezaee, Omid; Masafi M, Saeede; Mohamadrez; Farshad, Akbarpour Report Jun 1, 2012 2741
Use of Bristol-Myers Squibb's Oral Abilify is Shifting to First-Line Treatment of Newly Diagnosed Schizophrenia Patients. May 9, 2012 506
Latuda[R] (lurasidone HCl) Label Updated With Expanded Dosing Range Providing Added Flexibility for the Treatment of Patients with Schizophrenia. May 5, 2012 2437
TMS guided by fMRI not effective for hallucinations. Boschert, Sherry Clinical report Apr 1, 2012 464
Mylan Launches Generic Version of Seroquel[R] Tablets, 25 mg. Mar 28, 2012 413
Reviva Pharmaceuticals Announces Enrollment of Patients in Phase 2 Clinical Study of RP5063 for the Treatment of Schizophrenia and Schizoaffective Disorder. Clinical report Mar 12, 2012 933
Cheap acne antibiotic could help ease schizophrenia symptoms. Mar 3, 2012 392
Forest Laboratories, Inc. and Gedeon Richter Plc. Announce Results from Two Positive Phase III Trials with the Investigational Antipsychotic Cariprazine for the Treatment of Schizophrenia. Feb 28, 2012 1435
'Chemical cosh' drug doubles death risk in dementia patients. Feb 24, 2012 342
How antipsychotic medications lead to obesity and diabetes. Feb 2, 2012 546
FDA panel recommends loxapine for approval: from a meeting of the FDA's Psychopharmacologic Drugs Advisory Committee. Mechcatie, Elizabeth Jan 1, 2012 1047
Best practices in: the treatment of adults with schizophrenia: managing schizophrenia and overall health. Mattingly, Gregory W. Jan 1, 2012 1793
Alkermes Initiates Phase 3 Clinical Study of ALKS 9070 for Treatment of Schizophrenia. Dec 19, 2011 1161
New Drug Application for Otsuka's Once-Monthly Aripiprazole Depot Formulation for Maintenance Treatment of Adult Patients with Schizophrenia Accepted for Review by the U.S. Food and Drug Administration. Nov 22, 2011 990
Research and Markets: Global Schizophrenia Drug Pipeline Capsule - 2011. Sep 29, 2011 402
Monday, 26 September 2011 THEPROFESSIONALS; Ensuring that patients get right prescription for anti-psychotic drugs Dr Jane Harrison explains how the latest phase of 1,000 Lives Plus work on the appropriate use of anti-psychotic drugs will benefit patients. Sep 26, 2011 615
Groups back forcing meds. Correa, Frances Brief article Sep 1, 2011 158
When Compared to Other Atypical Antipsychotics, Fewer Schizophrenia Patients Who Take Zyprexa in the First Line Progress to a Second-Line Therapy within a Year. Jul 27, 2011 511
Cancer drugs may help treat schizophrenia. Jul 21, 2011 244
Alkermes Announces Positive Results from Clinical Study of ALKS 9070 For Treatment of Schizophrenia. Jun 30, 2011 948
Quality of life after electroconvulsive therapy in persons with treatment resistant schizophrenia. Garg, Rohit; Chavan, B.S.; Arun, Priti Report Jun 1, 2011 2292
Psychosocial treatments backed for schizophrenia. Jancin, Bruce May 1, 2011 883
INVEGA Approved as Treatment for Schizophrenia in Adolescents. Apr 11, 2011 2320
Risperdal(R) Consta(R) Associated With Lower Risk of Hospitalisation Compared to Treatment With Other Antipsychotics in Patients With Schizophrenia. Clinical report Mar 25, 2011 1584
New study could lead to potential drug targets for schizophrenia, Parkinson's. Mar 13, 2011 429
European Commission Approves XEPLION(R) for Treatment of Schizophrenia. Mar 9, 2011 1917
Cognition unaffected by single schizophrenia Tx. Tucker, Miriam E. Mar 1, 2011 929
The intersexual differences of sexual functions and prolactine levels in schizophrenia patients under antipsychotic medication/Antipsikotik tedavi uygulanan sizofreni hastalarinda prolaktin duzeyleri ve cinsel islevlerin cinsiyetlere gore karsilastirilmasi. Dogu, Basri; Kocabiyik, Ahmet; Karson, Fahri; Citak, Serhat; Incesu, Cem Report Mar 1, 2011 2929
Antipsychotics for schizophrenia linked to subtle loss in brain volume. Feb 8, 2011 294
Once-Daily Latuda[R] (lurasidone HCl) Now Available in Pharmacies Nationwide for the Treatment of Patients with Schizophrenia. Feb 3, 2011 2224
Latuda[R] (lurasidone HCl) Significantly Improves Symptoms of Schizophrenia in Fifth Positive Placebo-Controlled Study. Dec 8, 2010 2967
Phase II Study with First-in-Class Investigational Drug Demonstrates Improvement in Negative Symptoms in Patients with Schizophrenia. Dec 6, 2010 1338
Pimozide augmentation therapy in treatment-resistant schizophrenia patients with poor or partial response to clozapine: a retrospective study/Klozapin tedavisine yeterli yanit alinamayan tedaviye direncli sizofreni hastalarinda pimozidle guclendirme yaklasimi: geriye donuk bir degerlendirme calismasi. Kisa, Cebrail; Akdag, Hatice Alkan; Aydemir, Cigdem; Goka, Erol Report Dec 1, 2010 3825
FDA Approves Latuda to Treat Schizophrenia in Adults. Oct 28, 2010 503
FDA Approves Once-Daily LATUDA[R] (lurasidone HCL) for the Treatment of Patients with Schizophrenia. Oct 28, 2010 2200
Over the Next Three Years, Abilify and Seroquel XR Will Be the Fastest-Growing Drugs by Prescriptions for the Treatment of Major Depression. Oct 21, 2010 741
Dopamine model could aid treatment of schizophrenia, drug addiction. Oct 21, 2010 278
Otsuka Announces Phase 3 Aripiprazole Intramuscular (IM) Depot Trial Interim Analysis Reveals Efficacy Criteria Met. Oct 5, 2010 1884
New brain research could lead to schizophrenia treatment. Oct 1, 2010 225
Study finds frequent switching of antipsychotics. Helwick, Caroline Oct 1, 2010 557
AstraZeneca UK Receives Positive Decision For Seroquel XL(R)[Black Triangle Drug] (Quetiapine Prolonged Release) as an Add-On Treatment of Major Depressive Disorder. Sep 28, 2010 970
Drugs to treat nausea, vomiting 'up clots risk'. Sep 22, 2010 402
The quest for the correct dose: recent efforts shed light on antipsychotic dosing, but find much work is left to be done. Glazer, William M. Sep 1, 2010 1279
After Peaking at $6.3 Billion in 2011, Generic Erosion of Atypical Antipsychotics Will Cause the Schizophrenia Drug Market to Decline to $5.2 Billion in 2019. Aug 5, 2010 700
Committee for Medicinal Products for Human Use (CHMP) Issues Opinion on European Regulatory Filing for Merck's Atypical Antipsychotic Medication SYCREST[R] (asenapine). Jun 25, 2010 12118
Schizophrenia drug 'shrinks brain'. Jun 8, 2010 269
Schizophrenia drugs turn up volume of brain's key signaling system. May 15, 2010 257
New Study Finds Off-Label Use of Atypical Antipsychotics Increases Risk of Diabetes Among the Elderly. May 13, 2010 998
Early disruption of schizophrenia gene causes problems later. Sanders, Laura Brief article Mar 13, 2010 265
Antipsychotic polypharmacy in schizophrenic inpatients/Yatan sizofreni hastalarinda coklu antipsikotik kullanimi. Ozalmete, Ozlem Albayrak; Ceylan, Mehmet Emin; Ozalmete, Onur; Sevim, Meltem Efe Report Mar 1, 2010 4176
Augmentation of clozapine with pimozide: a case of a treatment-resistant schizophrenic patient/Klozapin tedavisini pimozid ile guclendirme yaklasimi: tedaviye direncli bir sizofreni olgusu. Akdag, Hatice Alkan; Kisa, Cebrail; Bekki, Gulcan; Goka, Erol Report Mar 1, 2010 2689
Emerging Oral Atypical Antipsychotics Will Garner Only Limited Uptake in the Schizophrenia Drug Market. Feb 23, 2010 643
Alkermes Unveils Long-Acting Injectable Proprietary Platform for Treatment of Schizophrenia and Other CNS Disorders. Feb 4, 2010 917
New biosensors show how drugs used to treat schizophrenia work. Dec 14, 2009 276
Aripiprazole approved for autism-related irritability. Mechcatie, Elizabeth Dec 1, 2009 454
Forest Laboratories, Inc. and Gedeon Richter Announce Positive Results from a Phase IIb Study of Cariprazine for the Treatment of Schizophrenia. Oct 28, 2009 1490
Epilepsy drug could raise schizophrenia risk. Oct 22, 2009 242
The outcome of behavioral intervention with a person living with schizophrenia who exhibited medication noncompliance: a case study. Kanahara, Shunsuke Case study Sep 22, 2009 3962
Injectable beats oral antipsychotics for bipolar. McNamara, Damian Clinical report Sep 1, 2009 593
Sublingual antipsychotic gets nod from FDA panel: asenapine safe, effective. Mechcatie, Elizabeth Aug 1, 2009 661
Schizophrenia drug may help fight cancer. Jun 3, 2009 175
'Singing brains' offer hope for better epilepsy, schizophrenia treatments. May 20, 2009 380
Titan Announces FDA Approval of Fanapt[TM] (Iloperidone) For the Treatment of Schizophrenia. May 7, 2009 359
ACADIA Pharmaceuticals and Meiji Seika Kaisha Form Collaboration to Develop and Commercialize a New Class of Pro-Cognitive Schizophrenia Drugs. Mar 25, 2009 1033
Prevalence of metabolic syndrome, characteristics of metabolic syndrome and relationship with the antipsychotics used in schizophrenia/Sizofrenide metabolik sendrom sikligi, metabolik sendromun ozellikleri ve kullanilan antipsikotiklerle iliskisi. Kaya, Mehmet Cemal; Virit, Osman; Altindag, Abdurrahman; Selek, Salih; Bulbul, Feridun; Bulut, Mahmu Clinical report Mar 1, 2009 4488
Drugs raise death rate for dementia patients. Clinical report Jan 9, 2009 444
WORLD TODAY: Alzheimer's drugs risk. Jan 9, 2009 98
FDA Approves New Injection Site for RISPERDAL(R) CONSTA(R) for Schizophrenia Treatment. Oct 9, 2008 1608
Off-label Medicine Combinations are Predominant Treatment of Schizophrenics According to PLoS Article. Sep 23, 2008 372
Ginkgo biloba and treatment resistant schizophrenia. Finney-Brown, Tessa Sep 22, 2008 488
Newer Antipsychotics No Better Than Older Drug in Treating Child and Adolescent Schizophrenia. Sep 15, 2008 113
LILLY (ELI) & COMPANY - Olanzapine Maintains Treatment Benefit in Schizophrenia. Sep 2, 2008 2354
Among women with schizophrenia who are being treated with antipsychotic medications, an estrogen patch can markedly improve their symptoms, results of a clinical trial show. Brief article Aug 11, 2008 285
BioLineRx Initiates Phase 2b Clinical Trials of BL-1020, a GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia. Jun 12, 2008 1109
FDA adds new indications for aripiprazole. Osborne, Randall Jun 1, 2008 187
New atypical shows efficacy for inpatients in early trial. Henderson, Gina L. Jun 1, 2008 413
ABILIFY(R) (aripiprazole) Receives Expanded Indications for Maintenance Treatment in Both Pediatric Patients (Aged 10-17) With Manic and Mixed Episodes of Bipolar I Disorder and Adolescents (Aged 13-17) With Schizophrenia. May 8, 2008 2196
MedImpact Study Highlights the Effects of Restricted Access on Use of Antipsychotic Drugs. Report Apr 29, 2008 496
ARYx Therapeutics Enters Clinic with Novel Antipsychotic Drug for Patients with Schizophrenia. Apr 22, 2008 1063
Antipsychotic drugs are doing harm. Mar 16, 2008 788
Getting the NAC of a novel schizophrenia Tx. Jancin, Bruce Mar 1, 2008 725
BioLineRx Announces Positive Results From Phase 2a Trial of BL-1020, a GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia. Feb 4, 2008 1299
ABILIFY approved for adolescent patients with schizophrenia. Dec 1, 2007 145
OREXIGEN(TM) Therapeutics to Present Data Supporting Novel, PreClinical Drug Combination for Schizophrenia. Nov 1, 2007 242
Elan Announces the Johnson & Johnson Pharmaceutical Research & Development Submission of a New Drug Application to the FDA for Paliperidone Palmitate Using Elan's Proprietary NanoCrystal(R) Technology. Oct 29, 2007 720
New Survey Conveys Fundamental Shift in the Perceptions of Treatment Outcomes in Schizophrenia. Oct 9, 2007 1028
Risperdal approved in teens for schizophrenia and BPD. Wachter, Kerri Sep 15, 2007 583
Wyeth drops after court ruling on protonix. Brief article Sep 10, 2007 220
Indications for risperidone expanded to teens, kids. Wachter, Kerri Sep 1, 2007 583
AstraZeneca's Once-Daily SEROQUEL XR(TM) Extended-Release Tablets Approved in Netherlands for the Acute and Long Term Treatment of Schizophrenia. Aug 29, 2007 617
CATIE results show overlap of schizophrenia, metabolic disorder. Kirn, Timothy F. Aug 1, 2007 435
BioLineRx Initiates Phase II Trial of BL-1020, a First in Class GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia. Jul 25, 2007 737
BioLineRx Initiates a Clinical Receptor-Occupancy Study of BL-1020, First in Class GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia. May 16, 2007 643
Antidepressants may benefit prepsychotic teens. Splete, Heidi May 1, 2007 330
The depot paradox: long-acting formulations of antipsychotics can boost treatment adherence rates, but clinicians have been hesitant to use them. Glazer, William M. May 1, 2007 2199
INVEGA(R) Receives Positive Opinion From European Committee for Human Medicinal Products for Treatment of Schizophrenia. Apr 27, 2007 688
The importance of early treatment of schizophrenia. Apr 1, 2007 2508
ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at the 2007 International Congress on Schizophrenia Research. Mar 29, 2007 1089
Weitz & Luxenberg Responds to Study on Off-Label Use of Antipsychotics. Feb 6, 2007 488
elbion and Wyeth Enter Collaboration to Develop New Treatments for Schizophrenia. Feb 5, 2007 552
Line of research could advance schizophrenia Tx. Goldman, Erik L. Feb 1, 2007 996
Off-label use of atypicals. Schneider, Mary Ellen Brief article Feb 1, 2007 163
Lilly reaches Zyprexa settlement. Schneider, Mary Ellen Brief article Feb 1, 2007 169
FDA approves new drug for schizophrenia. Feb 1, 2007 141
Omeros Receives up to $9 Million toward Development of Schizophrenia Treatment. Jan 10, 2007 470
Johnson & Johnson (New Brunswick NJ) won approval for its once-a-day pill called Invega for treating schizophrenia. Brief article Jan 8, 2007 120
FDA approves extended-release drug for schizophrenia. Walsh, Nancy Jan 1, 2007 386
Schizophrenia, substance use need integrated Tx: take into account the possible synergistic effects between antipsychotics and drugs of abuse. Sherman, Carl Jan 1, 2007 1125
Research and Markets: Market Research available on CNS Drug Discoveries 2006: Schizophrenia. Dec 15, 2006 559
Improved monitoring of lipids, glucose needed. Walsh, Nancy Dec 1, 2006 431
First agent for autism treats aggression, tantrums. McNamara, Damian Brief article Nov 15, 2006 264
CUtLASS findings interesting but inconclusive. Sullivan, Michele G. Clinical report Nov 1, 2006 758
HEALTH: Why the term schizophrenia only benefits the drug industry. Oct 10, 2006 178
Data on clozapine augmentation are scarce but do exist. Finn, Robert Aug 1, 2006 777
CATIE support of atypical antipsychotics debated. Kirn, Timothy F. Drug overview Jul 1, 2006 1209
BioLineRx to Present BL-1020, First in Class Small Molecule for the Treatment of Schizophrenia, at the American Psychiatric Association Annual Meeting. May 18, 2006 436
The Market for Typical or Atypical Antipsychotics for the Treatment of Schizophrenia Exceeded $5 Billion in 2005. May 18, 2006 515
Janssen-Cilag Submits Marketing Authorization Application in Europe for New Treatment for Schizophrenia. May 5, 2006 458
Clozapine 'wins again' in phase II of CATIE. McNamara, Damian May 1, 2006 644
BioLineRx Initiates Phase 1 Clinical Trials of BL-1020, First in Class Small Molecule for the Treatment Of Schizophrenia. Apr 10, 2006 515
Placing the risk of diabetes in context: based on an interview with Leslie Citrome, MD, MPH. Interview Apr 1, 2006 3685
The cognitive-behavioral treatment of schizophrenia: the state of the art and the evidence. Gaudiano, Brandon A. Mar 22, 2006 5535
Policy making's unintended consequences: line-item management of schizophrenia treatment is not cost-effective. Oss, Monica E. Mar 1, 2006 623
Olanzapine, haloperidol, and weight. Kirn, Timothy F. Brief article Mar 1, 2006 219
Drug combination fails to benefit clozapine-refractory schizophrenia. Lowry, Fran Mar 1, 2006 315
New Study Shows Equivalent Efficacy and Superior Tolerability of quetiapine Compared to risperidone in the Treatment of Schizophrenia. Jan 4, 2006 789
Medication noncompliance high among Asians with schizophrenia. Brunk, Doug Brief article Jan 1, 2006 289
Thinking on atypical dosages has changed: survey shows daily dosage of clozapine, risperdone down; trend is upward with olanzapine, quetiapine. Sherman, Carl Jan 1, 2006 727
Tapering off medications even with recent-onset schizophrenia a bad idea. Melville, Nancy A. Statistical data Jan 1, 2006 495
CATIE renews debate over old versus new antipsychotics: some experts warn against interpreting CATIE's findings as an endorsement of the typicals. Enos, Gary A. Jan 1, 2006 1313
Necessity drives schizophrenia polypharmacy. Sherman, Carl Dec 1, 2005 955
Schizophrenia prodrome therapies show promise: early intervention with antipsychotics and CBT appears to delay or prevent psychotic breaks. Mahoney, Diana Oct 1, 2005 1314
Medication compliance vital in schizophrenia Tx. MacNeil, Jane Salodof Aug 1, 2005 635
Cognitive side effects of anticholinergics. Leard-Hansson, Jan; Guttmacher, Laurence Aug 1, 2005 794
Antipsychotics' effects differ in substance abusers: activation of cytochrome P-450 system by cigarette smoke appears to play a role in drug metabolism. McNamara, Damian Jun 1, 2005 533
Dear healthcare professional. Lechleiter, John May 1, 2005 424
Important safety information for Zyprexa. May 1, 2005 360
Risperidone augmentation of clozapine works! Risperidone augmentation of clozapine doesn't work! A tale of two protocols. Citrome, Leslie May 1, 2005 1632
Dear healthcare professional. Lechleiter, John Apr 1, 2005 424
Important safety information for Zyprexa. Apr 1, 2005 338
Newer antipsychotics, hyperlipidemia. Foley, Kevin Brief Article Mar 1, 2005 167
SSRIs for negative symptoms of schizophrenia. Leard-Hansson, Jan; Guttmacher, Laurence Feb 1, 2005 771
Clozapine calms aggression. Splete, Heidi Brief Article Feb 1, 2005 132
Perspective. Bell, Carl C. Feb 1, 2005 352
Anticonvulsants in psychiatry: their similarities are different Part 2--clinical applications. Grady, Meghan M. Feb 1, 2005 855
Reducing violence in schizophrenia. Foley, Kevin Brief Article Jan 1, 2005 182
Amisulpride's real-world benefit shown in schizophrenia. Sullivan, Michele G. Jan 1, 2005 317
Choose atypicals for early onset schizophrenia: two drawbacks are the need for slow titration with younger patients and the high cost of newer agents. Walsh, Nancy Jan 1, 2005 908
Online schizophrenia algorithm almost ready: international effort took 3 years to finish. Sullivan, Michele G. Nov 1, 2004 538
High-dose ziprasidone effective for treatment-resistant schizophrenia. Finn, Robert Nov 1, 2004 437
Reducing clozapine's metabolic side effects. Leard-Hansson, Jan; Guttmacher, Laurence Nov 1, 2004 798
Compliance tougher in schizophrenia. McNamara, Damian Sep 1, 2004 692
Depot atypical antipsychotic maintains remission in some. Sherman, Carl Jul 1, 2004 474
Amisulpride vs. olanzapine. Evans, Jeff Brief Article Jul 1, 2004 132
Risperidone soothes teens' externalizing behavior: compared with olanzapine. McNamara, Damian Nov 1, 2003 381
Side effects guide antipsychotic drug choices: atypicals vs. typicals. Boschert, Sherry Oct 1, 2003 1034
Glutaminergics promising for cognitive, negative symptoms: amino acids for schizophrenia. Sherman, Carl Oct 1, 2003 473
Use caution when adding Rx to atypicals: augmenting psychotropics ill advised. (another antipsychotic drug). Sherman, Carl Oct 1, 2003 542
Antipsychotic weight gain. Evans, Jeff Brief Article Oct 1, 2003 131
Ziprasidone mesylate (Geodon for injection): the first injectable atypical antipsychotic medication. Sheehan, Valerie Clinical report Oct 1, 2003 4390
Genetic variation can cloud schizophrenia Tx: African american patients. (treatment). Zoler, Mitchel L. Sep 1, 2003 548
Alzheimer's drugs may boost schizophrenia therapy: rivastigmine, galantamine studied. Boschert, Sherry Aug 1, 2003 462
Novel antipsychotic's side effect profile offers benefits. (Neurotransmitter Systems Stabilized). Sherman, Carl May 1, 2003 539
Aripiprazole benefits are sustained over time. (Superior Side Effect Profile). Sherman, Carl Product/Service Evaluation May 1, 2003 558
Supratherapeutic dosing of olanzapine may help refractory schizophrenia. (Improved Social Functioning). Jancin, Bruce May 1, 2003 602
Cognition can be improved in schizophrenia. (Atypical Antipsychotics May Help). Jancin, Bruce May 1, 2003 583
Clozaril. (New & Approved). Mechacatie, Elizabeth Brief Article Feb 15, 2003 343
New & approved: elecsys proBNP immunoassay * aripiprazole. (Rx). Mechcatie, Elizabeth Jan 15, 2003 714
Aripiprazole wins approval for schizophrenia. (Unique Properties Not Yet Proven). Mechcatie, Elizabeth Jan 1, 2003 558
Studies support calming effect of Olanzapine. (More than 1,200 Patients). MacReady, Norra Jan 1, 2003 707
Olanzapine risks confirmed. (Clinical Capsules). Evans, Jeff Brief Article Dec 1, 2002 172
FDA approval likely for antipsychotic aripiprazole. (Different Mechanism of Action). Mechcatie, Elizabeth Oct 1, 2002 315
Olanzapine benefits older patients. (Versus Risperidone). Evans, Jeff Brief Article Oct 1, 2002 171
Ethnicity may affect antipsychotic Rx response. (South African Study). Mahoney, Diana Oct 1, 2002 670
Study finds adjunctive divalproex benefits acute schizophrenia. (First Double-Blind Frial). Walsh, Nancy Sep 1, 2002 329
Celecoxib for schizophrenia. (Clinical Capsules). Evans, Jeff Brief Article Jul 1, 2002 160
First atypical comparison may individualize care. (Chronic Schizophrenia). Splete, Heidi Brief Article Apr 1, 2002 559
Research on the drug treatment of schizophrenia: a critical appraisal and implications for social work education. Cohen, David (Dutch activist) Mar 22, 2002 10186
Practical psychopharmacology. (Cognitive Impairment in Schizophrenia). Sherman, Carl Brief Article Feb 1, 2002 881
Risperidone reduces relapse. (Clinical Capsules). Evans, Jeff Brief Article Feb 1, 2002 113
Clozapine Reduces Hostility. (Clinical Capsules). Evans, Jeff Brief Article Jan 1, 2002 121
Polypharmacy, Atypicals Top Pick For Schizophrenia. SHERMAN, CARL Sep 1, 2001 663
Data Reanalysis Suggests Optimal Dose for Atypical Antipsychotics. SHERMAN, CARL Sep 1, 2001 373
Integration of olanzapine determinations in a HPLC-diode array detection system for routine psychotropic drug monitoring. Llorca, Pierre M.; Coudore, Francois; Corpelet, Christophe; Buyens, Aurelie; Hoareau, Monique; Escha Sep 1, 2001 1509
Intramuscular Olanzapine Alleviates Acute Agitation. IMPERIO, WINNIE ANNE Aug 1, 2001 575
Atypical Improves Cognition in First Episode Psychosis. Walsh, Nancy Aug 1, 2001 228
Off-Label Anticonvulsants Useful in Schizophrenia. SHERMAN, CARL Aug 1, 2001 645
Antipsychotics Mean Higher Risk of MI, Arrhythmia for Some With Schizophrenia. Imperio, Winnie Anne Aug 1, 2001 256
Ziprasidone Offers Long-Term Symptom Control. WALSH, NANCY Aug 1, 2001 422
Once-Daily Antipsychotic Improves Schizophrenia. IMPERIO, WINNIE ANNE Jul 1, 2001 265
Olanzapine May Worsen Insulin Resistance. Walsh, Nancy Jul 1, 2001 248
Newer Antipsychotics Stabilize Schizophrenia Faster. WALSH, NANCY Brief Article Jul 1, 2001 240
Novel Antipsychotics May Be Best for Schizophrenia. MANN, ARNOLD Jul 1, 2001 217
Long-Acting Risperdal Improves Schizophrenia Symptoms. IMPERIO, WINNIE ANNE Jun 1, 2001 575
The Role of Medications in the Employment of People with Schizophrenia. Meyer, Piper S. Oct 1, 1999 6701
Schizophrenia: promising drug ... and infectious clues. Jun 18, 1994 540
Schizophrenia - a national tragedy. Jan 1, 1993 611
Price battle over schizophrenia drug. Bower, Bruce May 26, 1990 230
Schizophrenia drug gains FDA approval. Bower, B. Oct 14, 1989 273
Low-dose advantage for schizophrenics. Bower, Bruce Sep 24, 1988 604
Low-dose caveat for schizophrenia. Bower, Bruce Jun 13, 1987 350
Schizophrenia: new hope from an old drug. Bower, Bruce May 23, 1987 710

Terms of use | Copyright © 2015 Farlex, Inc. | Feedback | For webmasters